Updates

• 20 July 2022

  2020-2022 Technical Review Panel Observations Report

  The Global Fund is pleased to announce the release of the 2020-2022 Technical Review Panel Observations report.
• 10 June 2022

  Global Fund's Seventh Replenishment: How Can Implementing Countries Support?
• 24 May 2022

  Official response from ACT-Accelerator therapeutics partners to the IFPMA
• 20 May 2022

  Refocusing C19RM Investments to Maximize Impact

  The COVID-19 pandemic is evolving and so should C19RM investments. The Global Fund would like to support implementing countries to rethink how these funds need to be adapted to countries’ needs in a very dynamic pandemic context.
• 04 May 2022

  COVID-19 Clinical Therapeutics

  In this operational update, we would like to give you an update on COVID-19 testing and therapeutics that can be currently supported through the Global Fund’s COVID-19 Response Mechanism (C19RM), following WHO guidelines.
• 21 April 2022

  Update on the C19RM Health Product Management Template (HPMT)

  The C19RM Health Products Management Template has been updated to include TB cartridges (GeneXpert and Truenat). Principal Recipients can now procure these health products to support integrated testing of tuberculosis and COVID-19 under C19RM 2021 fi...